Zydus Life shares in focus today after US FDA approves cancer …
WEB2 days ago · Zydus Life shares gain 1% today after US FDA approves cancer drug worth $870 million. Zydus Lifesciences has received a significant approval from the US FDA for Enzalutamide capsules, which are ...
Zydus Receives Tentative Approval from USFDA for Enzalutamide …
WEB11 hours ago · Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration to manufacture Enzalutamide Tablets, 40 mg and 80 mg . ... Latest news about Zydus Lifesciences Limited . Zydus Lifesciences Gets Tentative Nod from US FDA for Enzalutamide Tablets 03:26am: MT ...
Zydus Lifesciences gets USFDA nod for Ahmedabad facility
WEB1 day ago · The US health regulator inspected Zydus Lifesciences’ transdermal patch manufacturing facility in Pharmez, Ahmedabad, between July 15 and July 19, the company stated in an exchange filing. The USFDA has now issued an EIR for the facility, classifying it as ‘Voluntary Action Indicated’ (VAI). Shares of Zydus Lifesciences Ltd gained nearly ...
Zydus ties up with CSIR-CDRI to develop drug for CKD-induced ...
WEB4 days ago · Updated On Sep 28, 2024 at 12:56 PM IST. New Delhi: Zydus Lifesciences on Friday said it has tied up with Lucknow-based CSIR-Central Drug Research Institute (CDRI) to develop a drug for chronic ...
Zydus ties up with CSIR-CDRI to develop drug for CKD-induced ...
WEB4 days ago · New Delhi: Zydus Lifesciences on Friday said it has tied up with Lucknow-based CSIR-Central Drug Research Institute (CDRI) to develop a drug for chronic kidney disease-induced osteoporosis. A collaborative research agreement was inked between the parties to develop oral medication through the discovery of small molecule inhibitors of Sclerostin, the Ahmedabad-based drug firm said in a ...
Zydus receives USFDA approval for ZITUVIO™ to treat adult …
WEBOct 20, 2023 · ZITUVIO™ contains active ingredient Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 ...
Zydus aims to launch first new drug in US by early 2026
WEBFeb 27 (Reuters) - India's Zydus Lifesciences (ZYDU.NS) is aiming to launch its first new drug in the United States by early 2026, looking to tap into the multi-billion dollar market for treating...
WEBZydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for ZITUVIOTM (Sitagliptin) tablets, 25 …
India's Zydus Lifesciences Q1 profit beats estimates on strong US ...
WEBAug 9, 2024 · Indian drugmaker Zydus Lifesciences reported a bigger-than-expected first-quarter profit on Friday, driven by strong demand for its generic respiratory drugs in its key market of North America.
Zydus Group Latest Update, News And Press Releases - Zydus Life
WEBZydus Cadila’s Sitagliptin Base Tablets Receives Tentative Approval from FDA. Get all the latest Zydus Group information, News, Videos, Press Releases and updates here.